Gwada-negative: The Rarest Blood Group on Earth

French scientists have discovered the world's rarest blood group, Gwada-negative, found in a woman from Guadeloupe. This groundbreaking finding highlights the complexity of human blood systems and the potential for future personalized transfusion solutions.
In a groundbreaking discovery, French scientists have identified the world's rarest blood group, known as "Gwada-negative." The only confirmed carrier is a woman from Guadeloupe, whose blood is so unique that no compatible donor has been found despite testing numerous potential samples. This discovery underscores the complexity of human blood systems beyond the familiar A, B, AB, and O types, which include the Rh factor. Blood groups are defined by specific proteins and sugars on the surface of red blood cells, crucial for transfusion compatibility.
The investigation began when the woman’s plasma reacted negatively with all tested donors’ blood samples, including her relatives, indicating an entirely new blood group. To pinpoint the cause, scientists employed advanced genetic analysis techniques, specifically whole exome sequencing, which examines all human genes. They discovered a mutation in the PIGZ gene, which encodes an enzyme essential for adding a sugar molecule to cell membrane components. This mutation prevents the addition of a specific sugar, resulting in a new antigen on red blood cells, leading to classification as Gwada-positive or -negative.
Further genetic experiments confirmed that this mutation creates a unique blood group. The woman remains the only known Gwada-negative individual, raising concerns about transfusion safety and her medical management. She has experienced mild intellectual disability and has lost two babies at birth, conditions potentially linked to her genetic mutation.
The PIGZ enzyme operates at the final stage of GPI (glycosylphosphatidylinositol) molecule synthesis, vital for cell membrane functions. Deficiencies in similar enzymes are associated with neurological issues and developmental delays. Given the extreme rarity of Gwada-negative blood, providing compatible transfusions in emergencies presents significant challenges. The possibility of lab-grown or genetically modified red blood cells offers a future solution, using stem cells to produce matching blood types for such rare cases.
This discovery adds Gwada to the growing roster of recognized blood group systems, now totaling 48. Named after Guadeloupe—"Gwada"—the blood group highlights the deep genetic diversity present in humans and the ongoing evolution of transfusion medicine. As genetic sequencing technology advances, scientists foresee more rare blood types being identified, which can improve personalized medical treatments and deepen our understanding of human variation.
Source: https://medicalxpress.com/news/2025-07-gwada-negative-rarest-blood-group.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Severe Flu During Pregnancy Can Break Fetal Barriers in Mice, Allowing Harmful Molecules to Enter the Brain
Severe influenza infection during pregnancy can compromise fetal brain barriers, allowing harmful molecules to enter the developing brain and potentially impact neurodevelopment. Learn about the latest findings from Illinois researchers.
The Role of TERRA, a Long Non-Coding RNA, in Human Aging and Alzheimer's Disease
New research reveals that the long non-coding RNA TERRA is linked to human aging and early stages of Alzheimer's disease, opening new avenues for biomarker development and understanding neurodegeneration.
Enhancing Concussion Care in Community Sports: A Call for Better Return-to-Play Protocols
Researchers highlight the need for improved concussion management and return-to-play protocols in community sports to protect long-term brain health of amateur athletes.
Innovative AI-Driven, Affordable Blood Tests for Early Alzheimer’s Detection
A team of scientists at the University of Liverpool has developed low-cost, AI-powered blood tests capable of detecting early signs of Alzheimer's disease, promising broader access to early diagnosis and treatment.



